Early Data Indicates an A.I.-Generated Drug Could Slow Aging
Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.
TL;DR
- Insilico Medicine's drug candidate, rentosertib, generated with AI assistance, may slow the aging process.
- New data from a clinical trial shows the drug reduced biological markers of age, as measured by AI 'aging clocks'.
- This development is a milestone in using AI for drug discovery and longevity research.
- The drug is still years away from regulatory approval, even for its intended use in patients with a chronic lung disease.
- Anti-aging effects have not yet been tested in healthy individuals.